The Law Offices of Frank R. Cruz announces an investigation of Supernus Pharmaceuticals, Inc. (“Supernus” or the “Company”) (NASDAQ: SUPN) on behalf of investors concerning the Company’s possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On April 8, 2024, Supernus announced that the FDA had issued a Complete Response
Jetzt den vollständigen Artikel lesen

NEW YORK, NY,, April 29, 2024 (GLOBE NEWSWIRE) -- Relativity Acquisition Corp. (Nasdaq: RACY) (the “Company”) today announced that, on April 23, 2024, the Company received a determination letter (the “Letter”) from the Nasdaq Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that Staff had determined to delist the Company’s securities
Jetzt den vollständigen Artikel lesen